The heads and the tails of malaria and VWF.

In this issue of Blood, O'Regan et al have extended our understanding of von Willebrand factor (VWF) in the pathogenesis of malaria. According to the World Health Organization (http://www.who.int/gho/malaria/en/), malaria affects 3.2 billion people in 97 countries with 198 million cases having occurred in 2013, and of those, 584 000 died. Ninety percent of those deaths in 2013 were children under the age of 5. The most devastating form of the disease is cerebral malaria, which occurs most frequently in young children. Although blood coagulation changes such as disseminated intravascular coagulation have been recognized since the 1970s, recent studies have focused on markers of these hemostatic changes as being most prevalent in cerebral malaria caused by Plasmodium falciparum. Cerebral malaria is more lethal in children than adults. Exchange transfusion has been used as an aggressive adjunct therapy for this condition.

[1]  Ian J. C. MacCormick,et al.  Laboratory evidence of disseminated intravascular coagulation is associated with a fatal outcome in children with cerebral malaria despite an absence of clinically evident thrombosis or bleeding , 2015, Journal of thrombosis and haemostasis : JTH.

[2]  H. Barman Exchange transfusion in complicated pediatric malaria: A critical appraisal , 2015, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

[3]  A. Craig,et al.  A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malaria. , 2014, Blood.

[4]  W. Aird,et al.  Plasmodium falciparum picks (on) EPCR. , 2014, Blood.

[5]  A. Craig,et al.  Severe Plasmodium falciparum Malaria Is Associated with Circulating Ultra-Large von Willebrand Multimers and ADAMTS13 Inhibition , 2008, PLoS pathogens.

[6]  P. D. de Groot,et al.  Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria. , 2007, The Journal of infectious diseases.

[7]  A. Craig,et al.  von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation , 2006, British journal of haematology.

[8]  P. D. de Groot,et al.  A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B. , 2005, Blood.

[9]  K. Mendis,et al.  ABO-blood-group types and protection against severe, Plasmodium falciparum malaria , 2005, Annals of tropical medicine and parasitology.

[10]  W. Marks,et al.  The effect of ABO blood group on the diagnosis of von Willebrand disease. , 1987, Blood.